Cite
HARVARD Citation
Luque, S. et al. (n.d.). PKP-010 Higher than recommended doses of colistimethate sodium in patients with multi-drug resistant gram-negative bacterial infections: a benefit or an increased risk of toxicity?. European journal of hospital pharmacy. pp. A135-A136. [Online].